THRD Third Harmonic Bio, Inc Year-over-year net earnings per share growth for the last 12 months
Reliance on external CROs and CMOs for molecule development creates a foundation for growth, as confirmed by the quarterly EPS growth valuation for Third Harmonic Bio (THRD). Resilience to macroeconomic shocks is characteristic of the defensive immunology sector, although a single-product focus creates binary risks. The current -80.60 figure determines the metric's magnitude, signaling the business's financial stability during periods of stagnation.
Third Harmonic Bio Inc - analytical breakdowns and key metrics (THRD)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Equity Ratio Third Harmonic Bio|THRD - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Third Harmonic Bio|THRD - Aggregate Debt Obligations|Debts to Book Capitalization Third Harmonic Bio, Inc|THRD - Long-Term Debt Volume|Company Short-Term Debt Third Harmonic Bio|Quick Ratio thirdharmonicbio.com
- earnings and market multiples details:
THRD - Company Profit|Future Profit Third Harmonic Bio|THRD - Company Value to Net Income|Forward P/E Multiple Third Harmonic Bio, Inc|THRD - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Third Harmonic Bio, Inc|THRD - Operating profit EBITDA|Earnings per share for the last twelve months Third Harmonic Bio|THRD - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months thirdharmonicbio.com|THRD - Net earnings per share growth this year|Net earnings per share growth forecast for next year Third Harmonic Bio
- company sales and revenue statistics:
Summary company analytics:Third Harmonic Bio, Inc. - THRD
This indicator measures the quarterly net profit per share trend, reflecting the efficiency of converting operating results into shareholder value. By analyzing the quarterly EPS growth rate, investors assess the pace of business scaling, which is critical for Third Harmonic Bio as it self-funds R&D research in allergology using existing cash reserves.
Competitors of Third Harmonic Bio (THRD)
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|ADPT: Year-over-year net earnings per share growth for the last 12 months|Celldex Corp - Year-over-year earnings per share growth rate for the last twelve months|AUPH: Quarterly EPS earnings growth|biocryst.com - Year-over-year earnings per one share growth for the last 12 months|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Dianthus Therapeutics Inc (DNTH) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Pharvaris Corp (PHVS)|ABCL (AbCellera Bio) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TRML (Tourmaline Bio, Inc.)|PGEN: Year-over-year earnings per share growth for the last 12 months|PHAR: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics Inc)|UPB: Quarterly EPS earnings growth|Zenas Corp - Year-over-year earnings per one share growth for the last 12 months|IMNM (Immunome, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth gossamerbio.com|Year-over-year earnings per share growth for the last twelve months KalVista Pharmaceuticals, Inc. (KALV)|SEPN (Septerna, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals Inc PVLA|SVRA - Year-over-year net earnings per share growth for the last 12 months|RIGL - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months anaptysbio.com|Astria Therapeutics, Inc. (ATXS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ENGN|RAPT (RAPT Therapeutics) - Quarterly EPS earnings growth|Aerovate (JBIO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ACRS|Year-over-year net earnings per share growth for the last 12 months kyvernatx.com KYTX|Tiziana Life Sciences Ltd - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months CABA|Ventyx Bio - Quarterly EPS earnings growth|THTX: Year-over-year earnings per share growth for the last twelve months|AVTX: Quarterly EPS earnings growth|ELDN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Agenus Inc.|Earnings per share growth in annualized terms for the last twelve months Climb Bio Inc. CLYM|Year-over-year net earnings per share growth for the last 12 months ZURA (Zura Bio)|Year-over-year earnings per share growth rate for the last twelve months ATYR|Quarterly EPS earnings growth ADAG (Adagene Inc.)|Year-over-year earnings per one share growth for the last 12 months IMA|STTK - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months EQ (Equillium, Inc.)|CNTB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months IMUX|Year-over-year earnings per share growth for the last twelve months Atara Biotherapeutics, Inc.|InflaRx GmbH - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth XFOR|ACET (adicetbio.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CELU (Celularity)|Quarterly EPS earnings growth INmune Bio Corporation INMB|BRNS - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months KZR (kezarlifesciences.com)|SAB Biotherapeutics, Inc. (SABS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Akari Therapeutics PLC|ENLV (Enlivex Therapeutics Ltd) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Q32 Bio Corp|Year-over-year net earnings per share growth for the last 12 months GOVX (GeoVax Labs, Inc.)|EDSA (edesabiotech.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IBIO (iBio)|Year-over-year net earnings per share change for the last twelve months Carisma Therapeutics Inc (CARM)|XTLB - Year-over-year earnings per share growth for the last twelve months|Bolt Biotherapeutics (BOLT) - Year-over-year net earnings per share growth for the last 12 months|hcwbiologics.com (HCWB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Aptevo Therapeutics Inc.|Year-over-year net earnings per share growth for the last 12 months AIM|Quarterly EPS earnings growth Aditxt Corp|Year-over-year earnings per share growth for the last twelve months GRI Bio Corp (GRI)|XORTX Corp - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth HIND (Vyome Holdings Inc)|revbiosciences.com (REVB) - Earnings per share growth in annualized terms for the last twelve months|INDP: Year-over-year net earnings per share growth for the last 12 months|Scinai Immunotherapeutics Ltd - Year-over-year earnings per share growth rate for the last twelve months|CALI: Quarterly EPS earnings growth|Affimed N.V. - Year-over-year earnings per one share growth for the last 12 months|ALLK (Allakos Inc) - Quarterly EPS earnings growth|HOOKIPA (HOOK) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months IGM Biosciences, Inc. (IGMS)|ITOS (iTeos Therapeutics Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth OCEA (Ocean Bio)|TCBP: Year-over-year earnings per share growth for the last 12 months
